Seoulin BioscienceLtd Management

Management Kriterienprüfungen 0/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Eul-Moon Hwang

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	n/a
Amtszeit als Geschäftsführer	no data
Eigentum des Geschäftsführers	29.8%
Durchschnittliche Amtszeit des Managements	keine Daten
Durchschnittliche Amtszeit der Vorstandsmitglieder	keine Daten

Jüngste Management Updates

Recent updates

Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070) Is An Attractive Dividend Stock - Here's Why

May 03

Should Weakness in Seoulin Bioscience Co.,Ltd.'s (KOSDAQ:038070) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Mar 13

Introducing Seoulin BioscienceLtd (KOSDAQ:038070), A Stock That Climbed 54% In The Last Year

Feb 15

Is Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070) A Great Dividend Stock?

Jan 20

Three Days Left Until Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070) Trades Ex-Dividend

Dec 25

Is Seoulin Bioscience Co.,Ltd.'s (KOSDAQ:038070) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Dec 06

Geschäftsführer

Eul-Moon Hwang

no data

Amtszeit

Eul-Moon Hwang is Chief Executive Officer of Seoulin Bioscience Co.,Ltd.

Seoulin BioscienceLtd Management

Management Kriterienprüfungen 0/4

Wichtige Informationen

Jüngste Management Updates

No independent directors

No independent directors

Recent updates

Seoulin Bioscience Co.,Ltd. (KOSDAQ:A038070) announces an Equity Buyback for KRW 1,000 million worth of its shares.

First quarter 2024 earnings released: EPS: ₩66.00 (vs ₩211 in 1Q 2023)

Upcoming dividend of ₩127 per share at 1.4% yield

Third quarter 2023 earnings released: EPS: ₩67.00 (vs ₩144 in 3Q 2022)

Full year 2022 earnings released: EPS: ₩1,163 (vs ₩1,918 in FY 2021)

Upcoming dividend of ₩97.56 per share

Investor sentiment improved over the past week

No independent directors

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

No independent directors

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Investor sentiment deteriorated over the past week

Upcoming dividend of ₩96.25 per share

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070) Is An Attractive Dividend Stock - Here's Why

Full year 2020 earnings released: EPS ₩636 (vs ₩1,143 in FY 2019)

Should Weakness in Seoulin Bioscience Co.,Ltd.'s (KOSDAQ:038070) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

New 90-day low: ₩12,000

Introducing Seoulin BioscienceLtd (KOSDAQ:038070), A Stock That Climbed 54% In The Last Year

Is Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070) A Great Dividend Stock?

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

New 90-day high: ₩17,850

Three Days Left Until Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070) Trades Ex-Dividend

Upcoming Dividend of ₩93.52 Per Share

New 90-day high: ₩14,650

Is Seoulin Bioscience Co.,Ltd.'s (KOSDAQ:038070) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Market bids up stock over the past week

New 90-day low: ₩11,250

New 90-day high - ₩12,750

Geschäftsführer

Amtszeit